Last edition
News about "Michelle Jones"
Astex and Genentech Partner to Develop Precision Small Molecule Therapies for Breast Cancer
Astex Pharmaceuticals has entered into an exclusive global research and licensing agreement with Genentech to advance small molecule therapies for breast cancer. The deal includes a USD 25 million upfront payment to Astex and potential milestone payments exceeding USD 490 million, alongside tiered royalties on future product sales.
Michelle Jones | 07/07/2026 | By News Bureau
Astex Partners with Genentech on Breast Cancer Therapy Research
Astex has entered an exclusive research and licensing agreement with Genentech for a breast cancer therapy program, with potential deal value exceeding USD 490 million plus tiered royalties.
Michelle Jones | 07/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy